Top Banner
SURGICAL MANAGEMENT OF MOYA MOYA DISEASE ----AFTER 15 CASES DR AMIT KUMAR GHOSH Consultant Neurosurgeon Institute Of Neurosciences, Kolkata
23
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: SURGICAL MANAGEMENT OF MOYA MOYA DISEASE

SURGICAL MANAGEMENT OF MOYA MOYA DISEASE

----AFTER 15 CASES

DR AMIT KUMAR GHOSH Consultant Neurosurgeon

Institute Of Neurosciences, Kolkata

Page 2: SURGICAL MANAGEMENT OF MOYA MOYA DISEASE

TOTAL NO OF MOYA MOYA DISEASE TREATED—25

OPERATED (revascularizations)—15

CHILDREN—10

ADULT—5

EDAMS—10 ( All children)

STA-MCA BYPASS and EDAMS—5 (All adult)

Page 3: SURGICAL MANAGEMENT OF MOYA MOYA DISEASE

Presentations ---

Infarcts--- 12

Hemorrhage--- 10

Progressive cognitive decline---- one

Both infarct and hemorrhage--- Two

Page 4: SURGICAL MANAGEMENT OF MOYA MOYA DISEASE

PRE-OPERATIVE EVALUATION—

CT / MRI SCAN– To diagnose hemorrhage and infarcts

6 VESSELS DSA --- To diagnose Moya Moya disease and also To assess STA and MCA

MR Perfusion scan–

To assess cerebral blood flow pre operative,

To assess improvement post-operatively

To decide need for surgery on asymptomatic hemisphere

Page 5: SURGICAL MANAGEMENT OF MOYA MOYA DISEASE

SURGERY–

Indication– Individualized depending on general and neurological status

EDAMS only or EDAMS and STA-MCA bypass

Page 6: SURGICAL MANAGEMENT OF MOYA MOYA DISEASE

ENCEPHALO-DURO-ARTERIO-MYO-SYNANGIOSIS

Page 7: SURGICAL MANAGEMENT OF MOYA MOYA DISEASE
Page 8: SURGICAL MANAGEMENT OF MOYA MOYA DISEASE

STA-MCA BYPASS

Page 9: SURGICAL MANAGEMENT OF MOYA MOYA DISEASE

MCA—M4

STA

Page 10: SURGICAL MANAGEMENT OF MOYA MOYA DISEASE

MCA Temporary clipping

Page 11: SURGICAL MANAGEMENT OF MOYA MOYA DISEASE

ANAESTHETIC CONSIDERATIONS -----

1. Normotension

2. Normocarbia or slightly raised EtCO2(40-45 mmHg)

3. Normothermia to mild hypothermia

4. No anesthesia technique has been shown to be superior to other

Page 12: SURGICAL MANAGEMENT OF MOYA MOYA DISEASE

RESULTS AND FOLLOW UP– FOR EDAMS only UPTO 1 YEAR

Mortality—Nil

One wound infection because of perforation of skin during STA dissection—However cured with conservative treatment

One chronic headache due to mal-positioning of bone flap.

No other morbidity. All Childs are going to school and their deficit were completely resolved.

Page 13: SURGICAL MANAGEMENT OF MOYA MOYA DISEASE

RESULTS AND FOLLOW UP OF STA-MCA bypass along with EDAMS—

Mortality –one, On 1st post operative day patient developed multiple infarcts in bilateral hemisphere and patient died on 7th post-operative day

( patient of Quasi-Moya Moya ds due to bilateral ICA occlusion with progressive cognitive decline)

One patient--- Did well clinically, but bypass did not work in post-op DSA.

Other patients– Did well clinically and bypass also worked in post-operative DSA.

Page 14: SURGICAL MANAGEMENT OF MOYA MOYA DISEASE

POST-OPERATIVE ANGIOGRAPHY AND MR perfusion scan

Page 15: SURGICAL MANAGEMENT OF MOYA MOYA DISEASE

Moyamoya disease is an extremely rare disorder in most parts of the world except in Japan, where the overall incidence is higher (0.35 per 100,000).

The pathogenesis of Moyamoya disease is unknown

Moyamoya disease is characterized by progressive intracranial vascular stenoses of the circle of Willis

LITERATURE REVIEW

Page 16: SURGICAL MANAGEMENT OF MOYA MOYA DISEASE

It is a disease that tends to affect children and adults in the third to fourth decades of life.

In children it tends to cause strokes or seizures.

In adults it tends to cause bleeding or strokes.

The clinical features are cerebral ischaemia (strokes), recurrent transient ischaemic attacks,haemorrhage, convulsions and/or migraine-like headaches.

Page 17: SURGICAL MANAGEMENT OF MOYA MOYA DISEASE

The diagnosis is initially suggested by CT, MRI, or angiogram.

The name derives from its angiographic image-- the "puff of smoke," refers to the appearance of multiple collateral vessels seen on angiography.

Page 18: SURGICAL MANAGEMENT OF MOYA MOYA DISEASE

• There is no Medical treatment for Moya Moya disease.

• The role of Aspirin: thought by some to reduce the incidence of microemboli from the micro-collaterals

• Surgery is the Mainstay of treatment to prevent furthur Ischemic and Hemorrhagic events

Page 19: SURGICAL MANAGEMENT OF MOYA MOYA DISEASE

Several surgical approaches have been suggested in treating moyamoya disease

These approaches are generally divided into two groups:

Direct Revascularisation- STA-MCA anastomosis

Indirect Revascularisation---

EDAMS (encephalo-duro-arterio-myo-synangiosis)

EMS (encephalomyosynangiosis),

EDAS (encephaloduroarteriosynangiosis),

multiple burr holes procedure

Superior cervical ganglionectomy

Cervical pericarotid sympathectomy

Page 20: SURGICAL MANAGEMENT OF MOYA MOYA DISEASE

With the direct STA-MCA surgery, increased blood supply is immediate

After the in-direct EDAMS, EDAS, EMS, and multiple burr holes surgeries, symptoms may seem to improve almost immediately and it will take probably 6-12 months before new vessels (blood supply) can develop sufficiently.

Post-operative angiography is best to be done between 6 months and 1 year

The development of EDAMS was an attempt to increase collateral circulation from both the middle meningeal artery and the superficial temporal artery

Page 21: SURGICAL MANAGEMENT OF MOYA MOYA DISEASE

A definite conclusion about whether to choose EDAMS or another procedure to treat moyamoya disease is unclear.

Clinical results of EDAMS show a greater reduction of the ischemic attacks in moyamoya disease, and angiograms taken after surgery show extensive collateral vessels on the ischemic brain. Therefore, EDAMS seems to be one of the more effective treatments for moyamoya disease.

Page 22: SURGICAL MANAGEMENT OF MOYA MOYA DISEASE

References1) Kuriyama S, Kusaka Y, Fujimura M, et al (2008). "Prevalence

and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey". Stroke 39 (1): 42–7.

2) Wakai K, Tamakoshi A, Ikezaki K, et al (1997). "Epidemiological features of moyamoya disease in Japan: findings from a nationwide survey". Clin Neurol Neurosurg 99 Suppl 2: S1–5.

3) Surgical Treatment of Moyamoya Disease: Operative Technique for Encephalo-duro-arterio-myo-synangiosis, Its Follow-up, Clinical Results, and Angiograms; Kinugasa, Kazushi M.D.; Mandai, Shinya M.D.; Kamata, Ichiro M.D.; Sugiu, Kenji M.D.; Ohmoto, Takashi M.D. Volume 32(4), April 1993, p 527–531

Page 23: SURGICAL MANAGEMENT OF MOYA MOYA DISEASE

THANK YOU